Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bufei pills (also known as Bufei Wan or 补肺丸) are a traditional Chinese medicine (TCM) herbal preparation formulated as large honey pills or teapills. The classic formulation consists of six key herbal ingredients: prepared Rehmannia root (Rehmannia glutinosa), tangshen/Codonopsis root (Codonopsis pilosula), honey-prepared milkvetch/Astragalus root (Astragalus membranaceus), honey-prepared white mulberry root-bark (Morus alba), tatarian aster root (Aster tataricus), and Chinese magnolivine/Schisandra fruit (Schisandra chinensis), with honey used as an excipient. In TCM, Bufei pills are used to replenish lung qi, nourish yin, and relieve cough and asthma. It is primarily indicated for lung-qi deficiency characterized by chronic cough, shortness of breath, weak cough, dry cough, sticky sputum, and dry throat and tongue. It is marketed as an over-the-counter (OTC) herbal product in China and as a dietary supplement internationally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bufei pills.